These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
307 related articles for article (PubMed ID: 23030423)
1. Detecting risk and predicting patient mortality in patients with extended-spectrum β-lactamase-producing Enterobacteriaceae bloodstream infections. Trecarichi EM; Cauda R; Tumbarello M Future Microbiol; 2012 Oct; 7(10):1173-89. PubMed ID: 23030423 [TBL] [Abstract][Full Text] [Related]
2. Bloodstream infection with extended-spectrum beta-lactamase-producing Enterobacteriaceae at a tertiary care hospital in New Zealand: risk factors and outcomes. Freeman JT; McBride SJ; Nisbet MS; Gamble GD; Williamson DA; Taylor SL; Holland DJ Int J Infect Dis; 2012 May; 16(5):e371-4. PubMed ID: 22401750 [TBL] [Abstract][Full Text] [Related]
3. Clinical significance of extended-spectrum beta-lactamases. Rodríguez-Baño J; Pascual A Expert Rev Anti Infect Ther; 2008 Oct; 6(5):671-83. PubMed ID: 18847405 [TBL] [Abstract][Full Text] [Related]
4. Predictors of mortality in patients with bloodstream infections caused by extended-spectrum-beta-lactamase-producing Enterobacteriaceae: importance of inadequate initial antimicrobial treatment. Tumbarello M; Sanguinetti M; Montuori E; Trecarichi EM; Posteraro B; Fiori B; Citton R; D'Inzeo T; Fadda G; Cauda R; Spanu T Antimicrob Agents Chemother; 2007 Jun; 51(6):1987-94. PubMed ID: 17387156 [TBL] [Abstract][Full Text] [Related]
5. Predominance of healthcare-associated cases among episodes of community-onset bacteraemia due to extended-spectrum β-lactamase-producing Enterobacteriaceae. Zahar JR; Lesprit P; Ruckly S; Eden A; Hikombo H; Bernard L; Harbarth S; Timsit JF; Brun-Buisson C; Int J Antimicrob Agents; 2017 Jan; 49(1):67-73. PubMed ID: 27890442 [TBL] [Abstract][Full Text] [Related]
6. A multinational survey of risk factors for infection with extended-spectrum beta-lactamase-producing enterobacteriaceae in nonhospitalized patients. Ben-Ami R; Rodríguez-Baño J; Arslan H; Pitout JD; Quentin C; Calbo ES; Azap OK; Arpin C; Pascual A; Livermore DM; Garau J; Carmeli Y Clin Infect Dis; 2009 Sep; 49(5):682-90. PubMed ID: 19622043 [TBL] [Abstract][Full Text] [Related]
7. Risk factors and outcome of extended-spectrum β-lactamase-producing Enterobacter cloacae bloodstream infections. Qureshi ZA; Paterson DL; Pakstis DL; Adams-Haduch JM; Sandkovsky G; Sordillo E; Polsky B; Peleg AY; Bhussar MK; Doi Y Int J Antimicrob Agents; 2011 Jan; 37(1):26-32. PubMed ID: 21075605 [TBL] [Abstract][Full Text] [Related]
8. Risk factors associated with extended-spectrum β-lactamase-producing Enterobacteriaceae nosocomial bloodstream infections in a tertiary care hospital: a clinical and molecular analysis. Muro S; Garza-González E; Camacho-Ortiz A; González GM; Llaca-Díaz JM; Bosques F; Rositas F Chemotherapy; 2012; 58(3):217-24. PubMed ID: 22814216 [TBL] [Abstract][Full Text] [Related]
10. Prevalence of extended-spectrum beta-lactamase-producing Enterobacteriaceae isolated from blood cultures in Africa. Sangare SA; Maiga AI; Guindo I; Maiga A; Camara N; Savadogo S; Diallo S; Bougoudogo F; Armand-Lefevre L; Andremont A; Maiga II Med Mal Infect; 2015 Sep; 45(9):374-82. PubMed ID: 26433872 [TBL] [Abstract][Full Text] [Related]
11. Outcomes and risk factors for mortality in community-onset bacteremia caused by extended-spectrum beta-lactamase-producing Escherichia coli, with a special emphasis on antimicrobial therapy. Kang CI; Wi YM; Ko KS; Chung DR; Peck KR; Lee NY; Song JH Scand J Infect Dis; 2013 Jul; 45(7):519-25. PubMed ID: 23509913 [TBL] [Abstract][Full Text] [Related]
12. Clinical significance and impact on mortality of extended-spectrum beta lactamase-producing Enterobacteriaceae isolates in nosocomial bacteremia. Menashe G; Borer A; Yagupsky P; Peled N; Gilad J; Fraser D; Riesenberg K; Schlaeffer F Scand J Infect Dis; 2001; 33(3):188-93. PubMed ID: 11303808 [TBL] [Abstract][Full Text] [Related]
15. Assessment of the clinical significance of production of extended-spectrum beta-lactamases (ESBL) by Enterobacteriaceae. Henshke-Bar-Meir R; Yinnon AM; Rudensky B; Attias D; Schlesinger Y; Raveh D Infection; 2006 Apr; 34(2):66-74. PubMed ID: 16703295 [TBL] [Abstract][Full Text] [Related]
16. [Mortality risk factors for bloodstream infections caused by extended-spectrum beta-lactamase-producing microorganisms]. Ferrández O; Grau S; Saballs P; Luque S; Terradas R; Salas E Rev Clin Esp; 2011 Mar; 211(3):119-26. PubMed ID: 21371702 [TBL] [Abstract][Full Text] [Related]
17. Clinical significance of infections caused by extended-spectrum β-lactamase-producing Enterobacteriaceae blood isolates with inducible AmpC β-lactamase. Cheong HS; Ko KS; Kang CI; Chung DR; Peck KR; Song JH Microb Drug Resist; 2012 Aug; 18(4):446-52. PubMed ID: 22409779 [TBL] [Abstract][Full Text] [Related]
18. Extended-spectrum beta-lactamases in Enterobacteriaceae: related to age and gender. Shah AA; Hasan F; Ahmed S; Hameed A New Microbiol; 2002 Jul; 25(3):363-6. PubMed ID: 12173781 [TBL] [Abstract][Full Text] [Related]
19. Screening for extended-spectrum beta-lactamase-producing Enterobacteriaceae among high-risk patients and rates of subsequent bacteremia. Reddy P; Malczynski M; Obias A; Reiner S; Jin N; Huang J; Noskin GA; Zembower T Clin Infect Dis; 2007 Oct; 45(7):846-52. PubMed ID: 17806048 [TBL] [Abstract][Full Text] [Related]
20. Countrywide spread of community- and hospital-acquired extended-spectrum beta-lactamase (CTX-M-15)-producing Enterobacteriaceae in Lebanon. Moubareck C; Daoud Z; Hakimé NI; Hamzé M; Mangeney N; Matta H; Mokhbat JE; Rohban R; Sarkis DK; Doucet-Populaire F J Clin Microbiol; 2005 Jul; 43(7):3309-13. PubMed ID: 16000453 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]